SlideShare a Scribd company logo
1 of 5
Download to read offline
LEPTOSPIROSIS - DIAGNOSIS & MANAGEMENT GUIDELINES
MODIFIED FAINE’S CRITERIA (2012)
PRESUMPTIVE DIAGNOSIS: PART A or PART (A+B) = 26 or more
PART (A+B+C) = 25 or more
POSSIBLE DIAGNOSIS: Scores between 20 and 25
CASE DEFINITION (ICMR & WHO-SEAR)
Suspected case Acute febrile illness with:
Myalgia (especially calf tenderness)
Conjunctival su
ff
usion
Headache
Prostration
History of exposure to possible leptospira-contaminated environment
Probable case Suspected case with:
Rapid diagnostic test positivity (IgM ELISA or MSAT)
Con
fi
rmed case Suspected or Probable case with:
Isolation of leptospira in culture or
PCR positivity or
MAT (single titre of 1:400 or above / fourfold rise in serial titres)
CLINICAL
(PART-A)
EPIDEMIOLOGICAL
(PART-B)
LABORATORY
(PART-C)
Headache 2 Rainfall 5 Isolation by
culture**
DIAGNOSIS
CERTAIN
Fever 2 Contact with
contaminated
environment
4 Positive PCR 25
Temperature
> 39* C
2 Animal contact 1 ELISA IgM
Positive*
15
Conjunctival
su
ff
usion
4 MSAT Positive* 15
Meningism 4 MAT*
(Single high
titre or Rising
titre - 4x rise)
15
Myalgia 4
Conjunctival
su
ff
usion +
Meningism +
Myalgia
10 *any one of the
tests only should
be considered
for scoring
Jaundice 1
Albuminuria /
Azotemia
2
Hemoptysis /
Dyspnea
2
**Ideal time for culture
Blood - Within 10 days
Urine - 10 to 30 days
CSF - Within 5 to 10 days
Leptospirosis - Suspected / Probable / Con
fi
rmed
90% of cases are
Mild Leptospirosis
(Fever, myalgia,
conjunctival suffusion,
headache BUT NO
JAUNDICE)
Around 10% cases are
Moderate / Severe Leptospirosis
(Fever, myalgia, conjunctival suffusion, headache + JAUNDICE +/-
Multi-organ involvement
Based on clinical
spectrum
OP Treatment
Doxycycline 100mg PO
BD x 7 days or
Amoxicillin 500mg PO
TDS x 7 days or
Ampicillin 500mg
PO TDS x 7days or
Azithromycin 500mg PO
OD x 3 days
Other supportive Rx*
*advise adequate
hydration, bed rest,
antipyretics etc.
RED FLAG SIGNS
(tachypnea, tachycardia
disproportionate to fever,
shock, altered sensorium,
oliguria, bleeding
manifestations etc.)
IP Treatment (Antibiotic Rx +/- Organ speci
fi
c Rx)
Antibiotic therapy:
Penicillin 1.5 million units IV QID x 7 days or
Ceftriaxone 1g IV BD x 7 days or
Doxycycline 200mg IV stat, then 100mg IV BD x 7days
(Doxycycline contraindicated in pregnancy)
Organ speci
fi
c therapy:
RENAL: renal involvement is common.
Mild - only proteinuria and no RFT derangement: No intervention
Severe - AKI: Fluid management +/- diuretics, electrolyte correction,
avoid nephrotoxic drugs, avoid hypotension and hypovolemia +/- RRT (if
indicated by standard RRT guidelines)
HEPATIC: acute liver failure is rare.
Avoid precipitating factors of hepatic encephalopathy - drugs
(hepatotoxic drugs, sedatives etc.), hypovolemia, hypokalemia,
alkalosis, constipation, UGI bleeding.
Jaundice, Hepatomegaly: No intervention
Hepatic encephalopathy: lactulose, rifaximin etc.
LUNG: Most dangerous complication
ARDS / Pulmonary hemorrhage: Continuous O2 therapy, Mechanical
ventilation (if indicated)
HEART:
Myocarditis / Arrhythmia: treatment of speci
fi
c arrhythmia
Shock: treat hypovolemia with
fl
uid replacement. If not responding, add
dopamine or dobutamine.
HEMATOLOGICAL:
Thrombocytopenia: Platelet transfusion (if indicated)
Coagulopathy: Vit.K 5-10mg IV x 3 days +/- Fresh Frozen Plasma
DIC: FFP +/- blood transfusion
NEUROLOGICAL:
Aseptic meningitis: Symptomatic and supportive management.
Hypokalemic paralysis: IV Potassium supplementation
MUSCULOSKELETAL:
Myalgia / Myositis / Rhabdomyolysis : Monitor CPK levels, adequate
hydration, monitor urine output and serum electrolytes.
Arthralgia: No intervention +/- analgesic-antipyretics
All Absent
Any one or more is
present
Always rule out other tropical diseases.
Mixed infections are common.
Important differential diagnosis include:
-Malaria
-Scrub typhus
-Dengue
-Hepatitis
-Enteric fever etc.
Leptospirosis
 Zoonotic
 Pathogenic spirochete – Leptospira interrogans
 Rodents and Cattle excrete these organisms in their urine, which contaminates soil and
waterbodies
 Mode of transmission: contact of abraded skin or mucous membrane with contaminated
environment
 Incubation period: Average 5-14 days with a range 2- 30 days
 Risk factors:
o Heavy rainfall and water logging
o Natural disasters like floods
o Seasonal – at the onset of monsoon
o Farmers
o Agricultural field workers
o Fishermen
o Sewer workers
o Livestock handlers
o Mason
o Residence in endemic area
 Presentation spectrum:
o Anicteric Leptospirosis: (90%) – Mild form presents like Acute undifferentiated fever
o Icteric Leptospirosis: (5-10%) – Moderate-Severe form
o Weil’s Disease (0-5%) – Severe form
 When to suspect Leptospirosis?
o Acute febrile illness + Risk factors + one or more of the following:
 Headache
 Myalgia
 Prostration
 Calf muscle tenderness
 Conjunctival suffusion
 Oliguria / Frothy urine
 Jaundice
 Haemorrhagic manifestations
 Meningeal irritation
 Nausea, Vomiting, Abdominal pain, Diarrhoea
 Lab investigations to support diagnosis: (Blood, CSF, Urine sample)
o MAT titre of 100/200/400 or above based on endemicity (preferred)
o IgM based immune assays
o Seroconversion or Four-fold rise in MAT titre between acute and convalescent sera
o Direct isolation of organism
o PCR test
 Lab investigations to assess severity:
o CBC, ESR
o RFT, LFT
o S. Electrolytes
o Urine Routine examination
o CPK
o CXR, ABG
 Management:
o IVF and correction of electrolytes
o Mild cases:
 Tab. Doxycycline 100mg PO BD X 7 days (preferred) or
 Tab. Azithromycin 500mg PO OD X 3 days
o Moderate / Severe cases:
 Inj. Penicillin 1.5 million units IV or IM Q6H X 7 days or
 Inj. Ceftriaxone 2g IV OD X 7 days
o Chemoprophylaxis:
 Tab. Doxycycline 200mg PO once a week or
 Tab. Azithromycin 250mg PO once/ twice a week
DIAGNOSTIC:
A + B = /> 26
OR
A + B + C = /> 25
POSSIBLE:
A + B = Between 20 to 25
CRITERIA

More Related Content

Similar to Leptospirosis Protocol for NABH accredition

Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
Bng Crz
 
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld, PharmD
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
Sandip Gupta
 
Viral haemorrhagic fevers (vhf) plus questions.
Viral haemorrhagic fevers (vhf) plus questions.Viral haemorrhagic fevers (vhf) plus questions.
Viral haemorrhagic fevers (vhf) plus questions.
Shaikhani.
 

Similar to Leptospirosis Protocol for NABH accredition (20)

Agn@rph case management
Agn@rph case managementAgn@rph case management
Agn@rph case management
 
Dhf
DhfDhf
Dhf
 
Neonatal sepsis ppp
Neonatal sepsis pppNeonatal sepsis ppp
Neonatal sepsis ppp
 
Renal Disorders.pptx
Renal Disorders.pptxRenal Disorders.pptx
Renal Disorders.pptx
 
Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010Dengue Cu Resident 01 2010
Dengue Cu Resident 01 2010
 
Infective Endocarditis Pediatrics
Infective Endocarditis PediatricsInfective Endocarditis Pediatrics
Infective Endocarditis Pediatrics
 
S Lecture
S LectureS Lecture
S Lecture
 
Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015Matthew Rosenfeld final presentation legionnaires 2015
Matthew Rosenfeld final presentation legionnaires 2015
 
8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis8. Nephrotic Syndrome & AcuteGlomerularNephritis
8. Nephrotic Syndrome & AcuteGlomerularNephritis
 
Sickle cell disease sandip
Sickle cell disease sandipSickle cell disease sandip
Sickle cell disease sandip
 
Diagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptxDiagnosis and examination of swollen lymph nodes ppt.pptx
Diagnosis and examination of swollen lymph nodes ppt.pptx
 
Acute Pancreatitis
Acute Pancreatitis Acute Pancreatitis
Acute Pancreatitis
 
Fever,Rash and.pptx
Fever,Rash and.pptxFever,Rash and.pptx
Fever,Rash and.pptx
 
Biliary emergencies.pptx
Biliary emergencies.pptxBiliary emergencies.pptx
Biliary emergencies.pptx
 
Thrombocytopenia in pregnancy
Thrombocytopenia in pregnancyThrombocytopenia in pregnancy
Thrombocytopenia in pregnancy
 
Dengue Fever - Rational Management
Dengue Fever - Rational ManagementDengue Fever - Rational Management
Dengue Fever - Rational Management
 
dengue .pptx
dengue .pptxdengue .pptx
dengue .pptx
 
Dengue in children (F) - Copy.ppt
Dengue in children (F) - Copy.pptDengue in children (F) - Copy.ppt
Dengue in children (F) - Copy.ppt
 
Acute glomerulonephritis in children .pptx
Acute glomerulonephritis in children .pptxAcute glomerulonephritis in children .pptx
Acute glomerulonephritis in children .pptx
 
Viral haemorrhagic fevers (vhf) plus questions.
Viral haemorrhagic fevers (vhf) plus questions.Viral haemorrhagic fevers (vhf) plus questions.
Viral haemorrhagic fevers (vhf) plus questions.
 

More from Manievelraaman Kannan

Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case ReportParkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Manievelraaman Kannan
 
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis SyndromeAllergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Manievelraaman Kannan
 
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case ReportBrugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Manievelraaman Kannan
 
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Manievelraaman Kannan
 

More from Manievelraaman Kannan (11)

Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESSManievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
Manievelraaman's APPROACH TO NEUROLOGICAL WEAKNESS
 
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case ReportParkinson Plus Syndrome - Multiple System Atrophy: Case Report
Parkinson Plus Syndrome - Multiple System Atrophy: Case Report
 
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis SyndromeAllergy Induced Acute Coronary Syndrome - Kounis Syndrome
Allergy Induced Acute Coronary Syndrome - Kounis Syndrome
 
Brugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case ReportBrugada Syndrome - A Cardiac Channelopathy: Case Report
Brugada Syndrome - A Cardiac Channelopathy: Case Report
 
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
Allergy Induced Myocardial Infarction - Kounis Syndrome / Coronary Hypersensi...
 
TB Myeloradiculopathy
TB MyeloradiculopathyTB Myeloradiculopathy
TB Myeloradiculopathy
 
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGNCOLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
COLLOID CYST OF BRAIN / CNS SPACE OCCUPYING LESIONS - BENIGN
 
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROMEAllergic Acute Coronary Syndrome - KOUNIS SYNDROME
Allergic Acute Coronary Syndrome - KOUNIS SYNDROME
 
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -EtiopathogenesisAbnormal Uterine Bleeding (AUB) -Etiopathogenesis
Abnormal Uterine Bleeding (AUB) -Etiopathogenesis
 
Micturition reflex / Neural control of Urination
Micturition reflex / Neural control of UrinationMicturition reflex / Neural control of Urination
Micturition reflex / Neural control of Urination
 
Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)Small Intestine TB (Tuberculosis)
Small Intestine TB (Tuberculosis)
 

Recently uploaded

Recently uploaded (20)

รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdfรายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
รายการตํารับยาแผนไทยแห่งชาติ ฉบับ พ.ศ. 2564.pdf
 
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHYTUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
TUBERCULINUM-2.BHMS.MATERIA MEDICA.HOMOEOPATHY
 
Effects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial healthEffects of vaping e-cigarettes on arterial health
Effects of vaping e-cigarettes on arterial health
 
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.GawadHemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
Hemodialysis: Chapter 2, Extracorporeal Blood Circuit - Dr.Gawad
 
World Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 pptWorld Hypertension Day 17th may 2024 ppt
World Hypertension Day 17th may 2024 ppt
 
hypo and hyper thyroidism final lecture.pptx
hypo and hyper thyroidism  final lecture.pptxhypo and hyper thyroidism  final lecture.pptx
hypo and hyper thyroidism final lecture.pptx
 
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPTAntiplatelets in IHD, Dose Duration, DAPT vs SAPT
Antiplatelets in IHD, Dose Duration, DAPT vs SAPT
 
CT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic traumaCT scan of penetrating abdominopelvic trauma
CT scan of penetrating abdominopelvic trauma
 
MRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptxMRI Artifacts and Their Remedies/Corrections.pptx
MRI Artifacts and Their Remedies/Corrections.pptx
 
Cardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac PumpingCardiovascular Physiology - Regulation of Cardiac Pumping
Cardiovascular Physiology - Regulation of Cardiac Pumping
 
Introducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European UnionIntroducing VarSeq Dx as a Medical Device in the European Union
Introducing VarSeq Dx as a Medical Device in the European Union
 
linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...linearity concept of significance, standard deviation, chi square test, stude...
linearity concept of significance, standard deviation, chi square test, stude...
 
Creating Accessible Public Health Communications
Creating Accessible Public Health CommunicationsCreating Accessible Public Health Communications
Creating Accessible Public Health Communications
 
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. MacklinScleroderma: Treatment Options and a Look to the Future - Dr. Macklin
Scleroderma: Treatment Options and a Look to the Future - Dr. Macklin
 
Multiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptxMultiple sclerosis diet.230524.ppt3.pptx
Multiple sclerosis diet.230524.ppt3.pptx
 
Video capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in childrenVideo capsule endoscopy (VCE ) in children
Video capsule endoscopy (VCE ) in children
 
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptxThe Orbit & its contents by Dr. Rabia I. Gandapore.pptx
The Orbit & its contents by Dr. Rabia I. Gandapore.pptx
 
Retinal consideration in cataract surgery
Retinal consideration in cataract surgeryRetinal consideration in cataract surgery
Retinal consideration in cataract surgery
 
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON  .pptxDIGITAL RADIOGRAPHY-SABBU KHATOON  .pptx
DIGITAL RADIOGRAPHY-SABBU KHATOON .pptx
 
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
Book Trailer: PGMEE in a Nutshell (CEE MD/MS PG Entrance Examination)
 

Leptospirosis Protocol for NABH accredition

  • 1. LEPTOSPIROSIS - DIAGNOSIS & MANAGEMENT GUIDELINES MODIFIED FAINE’S CRITERIA (2012) PRESUMPTIVE DIAGNOSIS: PART A or PART (A+B) = 26 or more PART (A+B+C) = 25 or more POSSIBLE DIAGNOSIS: Scores between 20 and 25 CASE DEFINITION (ICMR & WHO-SEAR) Suspected case Acute febrile illness with: Myalgia (especially calf tenderness) Conjunctival su ff usion Headache Prostration History of exposure to possible leptospira-contaminated environment Probable case Suspected case with: Rapid diagnostic test positivity (IgM ELISA or MSAT) Con fi rmed case Suspected or Probable case with: Isolation of leptospira in culture or PCR positivity or MAT (single titre of 1:400 or above / fourfold rise in serial titres) CLINICAL (PART-A) EPIDEMIOLOGICAL (PART-B) LABORATORY (PART-C) Headache 2 Rainfall 5 Isolation by culture** DIAGNOSIS CERTAIN Fever 2 Contact with contaminated environment 4 Positive PCR 25 Temperature > 39* C 2 Animal contact 1 ELISA IgM Positive* 15 Conjunctival su ff usion 4 MSAT Positive* 15 Meningism 4 MAT* (Single high titre or Rising titre - 4x rise) 15 Myalgia 4 Conjunctival su ff usion + Meningism + Myalgia 10 *any one of the tests only should be considered for scoring Jaundice 1 Albuminuria / Azotemia 2 Hemoptysis / Dyspnea 2 **Ideal time for culture Blood - Within 10 days Urine - 10 to 30 days CSF - Within 5 to 10 days
  • 2. Leptospirosis - Suspected / Probable / Con fi rmed 90% of cases are Mild Leptospirosis (Fever, myalgia, conjunctival suffusion, headache BUT NO JAUNDICE) Around 10% cases are Moderate / Severe Leptospirosis (Fever, myalgia, conjunctival suffusion, headache + JAUNDICE +/- Multi-organ involvement Based on clinical spectrum OP Treatment Doxycycline 100mg PO BD x 7 days or Amoxicillin 500mg PO TDS x 7 days or Ampicillin 500mg PO TDS x 7days or Azithromycin 500mg PO OD x 3 days Other supportive Rx* *advise adequate hydration, bed rest, antipyretics etc. RED FLAG SIGNS (tachypnea, tachycardia disproportionate to fever, shock, altered sensorium, oliguria, bleeding manifestations etc.) IP Treatment (Antibiotic Rx +/- Organ speci fi c Rx) Antibiotic therapy: Penicillin 1.5 million units IV QID x 7 days or Ceftriaxone 1g IV BD x 7 days or Doxycycline 200mg IV stat, then 100mg IV BD x 7days (Doxycycline contraindicated in pregnancy) Organ speci fi c therapy: RENAL: renal involvement is common. Mild - only proteinuria and no RFT derangement: No intervention Severe - AKI: Fluid management +/- diuretics, electrolyte correction, avoid nephrotoxic drugs, avoid hypotension and hypovolemia +/- RRT (if indicated by standard RRT guidelines) HEPATIC: acute liver failure is rare. Avoid precipitating factors of hepatic encephalopathy - drugs (hepatotoxic drugs, sedatives etc.), hypovolemia, hypokalemia, alkalosis, constipation, UGI bleeding. Jaundice, Hepatomegaly: No intervention Hepatic encephalopathy: lactulose, rifaximin etc. LUNG: Most dangerous complication ARDS / Pulmonary hemorrhage: Continuous O2 therapy, Mechanical ventilation (if indicated) HEART: Myocarditis / Arrhythmia: treatment of speci fi c arrhythmia Shock: treat hypovolemia with fl uid replacement. If not responding, add dopamine or dobutamine. HEMATOLOGICAL: Thrombocytopenia: Platelet transfusion (if indicated) Coagulopathy: Vit.K 5-10mg IV x 3 days +/- Fresh Frozen Plasma DIC: FFP +/- blood transfusion NEUROLOGICAL: Aseptic meningitis: Symptomatic and supportive management. Hypokalemic paralysis: IV Potassium supplementation MUSCULOSKELETAL: Myalgia / Myositis / Rhabdomyolysis : Monitor CPK levels, adequate hydration, monitor urine output and serum electrolytes. Arthralgia: No intervention +/- analgesic-antipyretics All Absent Any one or more is present Always rule out other tropical diseases. Mixed infections are common. Important differential diagnosis include: -Malaria -Scrub typhus -Dengue -Hepatitis -Enteric fever etc.
  • 3. Leptospirosis  Zoonotic  Pathogenic spirochete – Leptospira interrogans  Rodents and Cattle excrete these organisms in their urine, which contaminates soil and waterbodies  Mode of transmission: contact of abraded skin or mucous membrane with contaminated environment  Incubation period: Average 5-14 days with a range 2- 30 days  Risk factors: o Heavy rainfall and water logging o Natural disasters like floods o Seasonal – at the onset of monsoon o Farmers o Agricultural field workers o Fishermen o Sewer workers o Livestock handlers o Mason o Residence in endemic area  Presentation spectrum: o Anicteric Leptospirosis: (90%) – Mild form presents like Acute undifferentiated fever o Icteric Leptospirosis: (5-10%) – Moderate-Severe form o Weil’s Disease (0-5%) – Severe form  When to suspect Leptospirosis? o Acute febrile illness + Risk factors + one or more of the following:  Headache  Myalgia  Prostration  Calf muscle tenderness  Conjunctival suffusion  Oliguria / Frothy urine  Jaundice  Haemorrhagic manifestations  Meningeal irritation  Nausea, Vomiting, Abdominal pain, Diarrhoea  Lab investigations to support diagnosis: (Blood, CSF, Urine sample) o MAT titre of 100/200/400 or above based on endemicity (preferred) o IgM based immune assays o Seroconversion or Four-fold rise in MAT titre between acute and convalescent sera o Direct isolation of organism o PCR test
  • 4.  Lab investigations to assess severity: o CBC, ESR o RFT, LFT o S. Electrolytes o Urine Routine examination o CPK o CXR, ABG  Management: o IVF and correction of electrolytes o Mild cases:  Tab. Doxycycline 100mg PO BD X 7 days (preferred) or  Tab. Azithromycin 500mg PO OD X 3 days o Moderate / Severe cases:  Inj. Penicillin 1.5 million units IV or IM Q6H X 7 days or  Inj. Ceftriaxone 2g IV OD X 7 days o Chemoprophylaxis:  Tab. Doxycycline 200mg PO once a week or  Tab. Azithromycin 250mg PO once/ twice a week
  • 5. DIAGNOSTIC: A + B = /> 26 OR A + B + C = /> 25 POSSIBLE: A + B = Between 20 to 25 CRITERIA